Oily paste composition as well as preparation method and application thereof
By using specific proportions of semi-solid oils, vegetable oils and soothing agents in infant buttock care cream, an effective protective film is formed, which solves the problems of existing infant buttock care cream to isolate urine and improve barrier function, and achieves the Effective prevention and relief of diaper rash.
Patent Information
- Application Number
- CN202411140124.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-22
AI Technical Summary
The existing infant and young children's buttock care cream has allergic problems in isolating stool and emulsifiers, and mineral oil and mineral lipoma lead to poor breathability of the skin. The moisture absorption and astringency of zinc oxide can easily cause skin desquamation and dryness, which cannot effectively alleviate diaper rash. and red butt phenomenon.
An oily paste-like composition is adopted, containing semi-solid oils, vegetable oils, plant waxes, antioxidants, emulsifiers, thickeners and soothing agents, and an effective protective film is formed through specific proportions and preparation methods to isolate the urine and Improve barrier function.
The composition forms a gentle and safe protective film on the baby's skin, isolates urination, significantly prevents red butts, enhances skin barrier function, is suitable for infants and young children, and has a moderate cost and is simple to prepare, which is suitable for industrial production.
Smart Images

Figure BDA0005000777330000081 
Figure BDA0005000777330000111 
Figure BDA0005000777330000121
Abstract
Description
Technical Field
[0001] The invention relates to an oily ointment composition for improving diaper rash, a preparation method and application thereof, and belongs to the field of oily skin care products. Background Art
[0002] As people's daily living standards continue to improve, people's awareness of infant skin care is also increasing, and infant care is gradually becoming professional. However, infant skin barriers are weak, resistance is poor, and it is easy to be damaged. In addition, with the widespread use of diapers, infant buttocks often come into contact with urine, feces or other excrement, causing redness, itching, allergies, rashes, blisters and other skin symptoms, thus causing diaper rash.
[0003] At present, some of the infant diaper creams on the market use an oil-in-water emulsification system, but when used, the system cannot well isolate urine and feces and is susceptible to allergies of the emulsifier, and thus cannot alleviate the phenomenon of infant diaper rash. For example, the diaper cream prepared by using a water-based silicone emulsifier in CN201811174174 cannot form an effective protective film on the skin surface to isolate urine and feces. The use of borneol and cyclopentasiloxane will also increase the irritation of the product and cannot effectively prevent the occurrence of infant diaper rash. Another part of the infant diaper creams on the market use mineral oil, petrolatum and zinc oxide ingredients. However, mineral oil and petrolatum are mineral-derived and have strong occlusive properties, which can easily cause poor air permeability of baby's skin, causing skin discomfort, and thus cannot significantly improve the problem of red buttocks; although zinc oxide is often used to deal with baby's red buttocks and diaper rash, and also has an auxiliary effect on acute dermatitis, prickly heat, and neck drowning, its strong hygroscopic and astringent effect can easily cause skin desquamation, dehydration, and dryness, and is not suitable for damaged skin, eczema skin, dermatitis skin, senile pruritus, etc. For example, CN202011127009 uses three ingredients, mineral oil, petrolatum and zinc oxide, but it does not have a good anti-inflammatory effect, and is prone to allergies, and thus cannot effectively relieve the baby's red buttocks phenomenon. Summary of the invention
[0004] In view of the above-mentioned defects of the prior art infant diaper cream, the object of the present invention is to provide an oily ointment composition for improving diaper rash, and a preparation method and application thereof. The oily ointment composition for improving diaper rash of the present invention has significant water-isolating, moisturizing, long-term and short-term soothing and barrier function improvement effects, and is therefore particularly suitable for preparing skin care products for improving infant diaper rash.
[0005] According to a first aspect, the present invention provides an oily ointment composition, characterized in that, in terms of weight percentage, the composition comprises: 20-59% semi-solid oil, 0.5-85% vegetable oil, 5-15% vegetable wax, 0.5-5% antioxidant, 1-53% emulsifier, 0.05-16% thickener and 0.01-5% soothing agent.
[0006] In some embodiments, the composition comprises, by weight percentage: 30-50% semi-solid oil, 10-65% vegetable oil, 5-10% vegetable wax, 0.5-3% antioxidant, 1-20% emulsifier, 0.05-10% thickener and 0.01-3% soothing agent.
[0007] In some embodiments, the semi-solid fat may be lanolin.
[0008] In some embodiments, the vegetable oil may be selected from at least one of solid vegetable oil and liquid vegetable oil.
[0009] In some embodiments, the plant wax can be selected from at least one of carnauba wax, candelilla wax, sumac wax, sunflower seed wax, NARCISSUS POETICUS flower wax, CITRUS AURANTIUM DULCIS flower wax, rice bran wax, green wattle flower wax and olive oil unsaponifiables.
[0010] In some embodiments, the antioxidant may be selected from at least one of tocopherol and ascorbyl ester.
[0011] In some embodiments, the emulsifier may be selected from at least one of polyglyceryl-2 triisostearate, polyglyceryl-2 diisostearate, polyglyceryl-2 oleate, polyglyceryl-10 decastearate, polyglyceryl-6 pentaoleate, polyglyceryl-10 decooleate, and polyglyceryl-6 polyricinoleate.
[0012] In some embodiments, the thickener may be selected from at least one of dextrin palmitate, dextrin palmitate / ethylhexanoate, and glyceryl behenate.
[0013] In some embodiments, the soothing agent may be selected from at least one of bisabolol, Centella asiatica extract, glycyrrhizin stearate, Lithospermum officinale extract, Perilla frutescens seed extract, Calendula officinalis extract, and Olive extract.
[0014] In some embodiments, the solid vegetable oil may be selected from at least one of cocoa seed butter, shea butter, garcinia indica seed butter, mango seed butter and coconut oil.
[0015] In some embodiments, the liquid vegetable oil can be selected from at least one of jojoba seed oil, sunflower seed oil, white meadowfoam seed oil, sea buckthorn seed oil, avocado tree butter, olive oil, camellia oil, almond oil, sweet almond oil, wheat germ oil, oat kernel oil avocado oil, macadamia seed oil, evening primrose oil, rice bran oil, camellia seed oil and moringa seed oil.
[0016] Particularly preferably, in the present invention, the unsaponifiable matter of oleoyl olive oil uses a compound formula product with the trade name of OLIWAX, which comprises hydrogenated olive oil, olive (OLEA EUROPAEA) fruit oil and olive (OLEA EUROPAEA) oil unsaponifiable matter; and the sunflower seed oil and antioxidant use a compound formula product with the trade name of DERMOFEEL TOCO 50 NON-GMO, which comprises sunflower (HELIANTHUS ANNUUS) seed oil and tocopherol (vitamin E).
[0017] According to a second aspect, the present invention provides a method for preparing the oily paste composition according to the first aspect, characterized in that the method comprises the following steps:
[0018] S1: mixing the vegetable wax, vegetable oil and emulsifier under stirring conditions, and heating and keeping warm to obtain a phase A solution;
[0019] S2: adding the semi-solid oil, antioxidant, soothing agent and thickener to the phase A solution obtained in the above step S1 in sequence, mixing under stirring conditions, and heating and keeping warm to obtain a phase B solution;
[0020] S3: Cooling the phase B solution obtained in the above step S2 to a certain temperature and filtering it to obtain a phase C solution;
[0021] S4: placing the phase C solution obtained in the above step S3 at a certain cold air channel temperature, without refrigeration, and filling under low wind until the paste solidifies to obtain the oily paste composition; or
[0022] The phase C solution obtained in the above step S3 is placed in a naturally cooled state without refrigeration or blowing and filled until the paste solidifies to obtain the oily paste composition.
[0023] In some embodiments, the method satisfies at least one of the following conditions:
[0024] In step S1, the heating and heat preservation refers to heating to 85-90°C and keeping warm for 10-15 minutes;
[0025] In step S2, the heating and heat preservation refers to heating to 85-90° C. and keeping warm for 10-15 minutes;
[0026] In step S3, the certain temperature is 80-85°C; and
[0027] In step S4, the certain cold air temperature is 15-20°C.
[0028] According to a second aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product for improving diaper rash in infants and young children.
[0029] According to a third aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product with a water-isolating effect.
[0030] According to a fourth aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product with a moisturizing effect.
[0031] According to a fifth aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product with a short-term soothing effect.
[0032] According to a sixth aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product with a long-lasting soothing effect.
[0033] According to a seventh aspect, the present invention provides use of the oily ointment composition according to the first aspect or the oily ointment composition prepared according to the method described in the second aspect in preparing a skin care product having an effect of improving barrier function.
[0034] The oily paste composition of the present invention has the following technical effects:
[0035] 1. Different from the oil-in-water emulsion in the prior art, the novel composition for preventing diaper rash of the present invention is a full-oil paste product mainly composed of a specific content of semi-solid oil, vegetable oil, vegetable wax and soothing agent. The product can form an effective protective film on the baby's skin surface, reduce skin friction, isolate feces and urine, and effectively prevent the occurrence of diaper rash. The formula is mild, safe, non-irritating, and hormone-free. It can be stored for a long time and is very suitable for infants and young children.
[0036] 2. The novel oily ointment composition for preventing diaper rash provided by the present invention uses ingredients of animal and plant origin, removes traditional zinc oxide and mineral oil and petrolatum ingredients, and uses appropriate ingredient ratios and a scientific preparation method rather than simply superimposing raw material ingredients to make the ingredients work together and give full play to their respective effects. In addition, the present invention has moderate cost, simple preparation process, and convenient operation, which is beneficial to industrial production.
[0037] 3. The new oily ointment composition for preventing diaper rash provided by the present invention has a moisturizing and non-sticky feel, is easily absorbed by the skin, and the protective film produced can separate harmful substances in feces and urine from the skin for a long time, providing the baby with a dry and comfortable butt environment; at the same time, it can also enhance the baby's skin barrier function, promote skin resistance, and further effectively prevent and improve the condition of red buttocks. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 : is a photograph taken under a microscope showing the immunofluorescence results of filaggrin (FLG) in Experimental Example 5, wherein BC represents a blank control group, NC represents a negative control group, and PC represents a positive control group. Figure 1 As can be seen from the photographs, compared with the BC group, the NC group and the PC group, the content of filaggrin (FLG) in the skin of the sample coated with the oily cream composition prepared in Example 5 increased significantly. DETAILED DESCRIPTION
[0039] Embodiment 1:
[0040] S1: Heat OLIWAX, Jarplex SB35, sea buckthorn seed oil and polyglyceryl-2 triisostearate to 85°C under stirring according to the amounts shown in Table 1, and keep the temperature for 10 minutes to obtain a phase A solution;
[0041] S2: Add anhydrous lanolin, DERMOFEEL TOCO 50NON-GMO, bisabolol, stearyl glycyrrhetinate and dextrin palmitate to the phase A solution obtained in step S1 in sequence according to the amounts shown in Table 1, and keep the mixture at 85°C for 10 minutes under stirring to obtain a phase B solution;
[0042] S3: Cool the phase B solution to 80°C and filter to obtain the phase C solution, i.e., the original solution of the composition;
[0043] S4: Fill 45 g of the original composition solution at a cold air channel temperature of 15°C, without refrigeration and with low wind until the paste solidifies to obtain 45 g of an oily paste composition; or
[0044] The original liquid of the composition was filled in 5 g form without refrigeration or blowing and naturally cooled until the paste solidified to obtain 5 g of an oily paste composition.
[0045] Embodiment 2:
[0046] S1: Heat OLIWAX, Jarplex SB35, sea buckthorn seed oil and polyglyceryl-2 triisostearate to 90°C under stirring according to the amounts shown in Table 1, and keep the mixture warm for 10 minutes to obtain a phase A solution;
[0047] S2: Add anhydrous lanolin, DERMOFEEL TOCO 50NON-GMO, bisabolol, stearyl glycyrrhetinate and dextrin palmitate to the phase A solution obtained in step S1 in sequence according to the amounts shown in Table 1, and keep the mixture at 90° C. for 10 minutes under stirring to obtain a phase B solution;
[0048] S3: Cool the phase B solution to 85°C and filter to obtain the phase C solution, i.e., the original solution of the composition;
[0049] S4: Fill 45 g of the original liquid of the composition at a cold air channel temperature of 20° C., without refrigeration and with low wind until the paste solidifies to obtain 45 g of an oily paste composition; or
[0050] The original liquid of the composition was filled in 5 g form without refrigeration or blowing and naturally cooled until the paste solidified to obtain 5 g of an oily paste composition.
[0051] Embodiment 3:
[0052] S1: Heat OLIWAX, Jarplex SB35, sea buckthorn seed oil and polyglyceryl-2 triisostearate to 85°C under stirring according to the amounts shown in Table 1, and keep the mixture warm for 15 minutes to obtain a phase A solution;
[0053] S2: Add anhydrous lanolin, DERMOFEEL TOCO 50NON-GMO, bisabolol, stearyl glycyrrhetinate and dextrin palmitate to the phase A solution obtained in step S1 in sequence according to the amounts shown in Table 1, and keep the mixture at 85°C for 15 minutes under stirring to obtain a phase B solution;
[0054] S3: Cool the phase B solution to 85°C and filter to obtain the phase C solution, i.e., the original solution of the composition;
[0055] S4: Fill 45 g of the original liquid of the composition at a cold air channel temperature of 20° C., without refrigeration and with low wind until the paste solidifies to obtain 45 g of an oily paste composition; or
[0056] The original liquid of the composition was filled in 5 g form without refrigeration or blowing and naturally cooled until the paste solidified to obtain 5 g of an oily paste composition.
[0057] Embodiment 4:
[0058] S1: Heat OLIWAX, Jarplex SB35, sea buckthorn seed oil and polyglyceryl-2 triisostearate to 87°C under stirring according to the amounts shown in Table 1, and keep the temperature for 13 minutes to obtain a phase A solution;
[0059] S2: Add anhydrous lanolin, DERMOFEEL TOCO 50NON-GMO, bisabolol, stearyl glycyrrhetinate and dextrin palmitate to the phase A solution obtained in step S1 in sequence according to the amounts shown in Table 1, and keep the mixture at 87°C for 14 minutes under stirring to obtain a phase B solution;
[0060] S3: Cool the phase B solution to 82°C and filter to obtain the phase C solution, i.e., the original solution of the composition;
[0061] S4: Fill 45 g of the original composition solution at a cold air channel temperature of 15°C, without refrigeration and with low wind until the paste solidifies to obtain 45 g of an oily paste composition; or
[0062] The original liquid of the composition was filled in 5 g form without refrigeration or blowing and naturally cooled until the paste solidified to obtain 5 g of an oily paste composition.
[0063] Embodiment 5:
[0064] S1: Heat OLIWAX, Jarplex SB35, sea buckthorn seed oil and polyglyceryl-2 triisostearate to 88°C under stirring according to the amounts shown in Table 1, and keep the temperature for 10 minutes to obtain a phase A solution;
[0065] S2: according to the amounts shown in Table 1, anhydrous lanolin, DERMOFEEL TOCO 50NON-GMO, bisabolol, stearyl glycyrrhetinate and dextrin palmitate were sequentially added to the phase A solution obtained in step S1, and the mixture was kept at 88° C. for 15 minutes under stirring to obtain a phase B solution;
[0066] S3: Cool the phase B solution to 85°C and filter to obtain the phase C solution, i.e., the original solution of the composition;
[0067] S4: Fill 45 g of the original composition solution at a cold air channel temperature of 17° C., without refrigeration and with low wind until the paste solidifies to obtain 45 g of an oily paste composition; or
[0068] The original liquid of the composition was filled in 5 g form without refrigeration or blowing and naturally cooled until the paste solidified to obtain 5 g of an oily paste composition.
[0069] Table 1: Component ratio of the oily ointment composition of Examples 1-5 (expressed in g)
[0070]
[0071] Experimental Example 1: Stability Test
[0072] The specific method of stability testing is as follows:
[0073] 1) preparing a certain number of samples (the oily paste compositions of Examples 1-5);
[0074] 2) Place the samples at 5°C, room temperature, 40°C and 50°C under cyclic conditions for a total of 3 months;
[0075] 3) Take out samples every half a month and observe changes in appearance, odor, color, hardness, etc. after returning to room temperature.
[0076] The results of the stability test are shown in Table 2 below.
[0077] Table 2: Stability of the oily ointment compositions of Examples 1-5 under different conditions for 3 months
[0078] condition Example 1 Example 2 Example 3 Example 4 Example 5 5℃ OK OK OK OK OK Room temperature OK OK OK OK OK 40℃ OK OK OK OK OK 50℃ OK OK OK OK OK cycle OK OK OK OK OK
[0079] Note: The cycle is -5℃ and 40℃ every 24 hours.
[0080] Experimental Example 2: Waterproofing Test
[0081] Method 1. Franz diffusion cell test
[0082] The Franz diffusion cell method uses artificial membranes, in vitro membranes, animal skins such as suckling pig skin or mouse skin, and adds different samples to the skin or membrane surface for transdermal experiments. The water barrier properties of the samples are evaluated by calculating the accumulated permeation amount, permeability and recovery rate.
[0083] The specific test method of the Franz diffusion cell method is as follows: ① Cut the NC membrane or skin membrane type to the pore size; ② Provide PBS in the receiving cell and the supply cell of the diffusion cell respectively, put them in a 32°C water bath for preheating, and then pour out the PBS in the supply cell; ③ Add an appropriate amount of the oily paste composition sample of Examples 1-5 to the supply cell, cover the supply cell with plastic wrap and tin foil, and place it in a 32°C water bath; ④ Use a syringe to insert from the sampling tube to the sampling point to take samples at 1h, 2h, 4h, 6h and 16h, and the results are shown in Tables 3-5.
[0084] The judgment criteria of the Franz diffusion cell method are as follows: the recovery rate is within the range of 90-110% and is considered valid data; the cumulative permeation volume and permeability are lower than NC, which means that the test sample has a certain water barrier property.
[0085] The results are shown in Tables 3-5 below.
[0086] Table 3: Fzanz diffusion cell recovery results of the oily paste compositions of Examples 1-5
[0087] Sampling time / h NT Example 1 Example 2 Example 3 Example 4 Example 5 6h 90% 91.1% 90.5% 90.8% 90.2% 90.8%
[0088] Table 4: Fzanz diffusion cell cumulative permeation results of the oily ointment compositions of Examples 1-5
[0089] Sampling time / h NT Example 1 Example 2 Example 3 Example 4 Example 5 1h 0.2 0.28 0.23 0.15 0.14 0.17 2h 0.63 0.59 0.62 0.475 0.52 0.33 4h 0.95 0.93 0.88 0.81 0.84 0.75 6h 1.18 1.01 0.95 1.12 1.02 0.9
[0090] Table 5: Fzanz diffusion cell permeability results of the oily paste compositions of Examples 1-5
[0091] Sampling time / h NT Example 1 Example 2 Example 3 Example 4 Example 5 1h 6% 8% 7% 4% 4% 5% 2h 19% 18% 19% 14% 16% 10% 4h 28% 28% 26% 24% 25% 22% 6h 35% 30% 28% 34% 31% 27%
[0092] From the results of Table 3, Table 4 and Table 5, it can be seen that after 6 hours of testing the oily paste compositions of Examples 1-5 using the Franz diffusion cell method, the cumulative penetration amount and permeability are significantly lower, indicating that the oily paste compositions of Examples 1-5 have significant water-isolating effects.
[0093] Method 2. Contact angle test
[0094] The contact angle test method is to evenly apply an appropriate amount of the oily paste composition sample of Examples 1-5 on pig skin, and then measure the contact angle of the applied sample using a fully automatic contact angle measuring instrument after it is left to stand for several minutes under a constant temperature and humidity environment. If the contact angle is less than 90°C, the sample to be tested is determined to be hydrophilic; if the contact angle is greater than 90°C, the sample to be tested is determined to be hydrophobic.
[0095] The results are shown in Table 6 below.
[0096] Table 6: Contact angle test results of the oily paste compositions of Examples 1-5
[0097] Test items Example 1 Example 2 Example 3 Example 4 Example 5 Contact Angle 93.25° 92.38° 94.78° 92.69° 91.79°
[0098] From the results in Table 6, it can be seen that, after the pig skin contact angle test, the contact angles of the oily ointment compositions of Examples 1-5 are all greater than 90°, indicating that the oily ointment compositions of the present invention are hydrophobic.
[0099] Experimental Example 3: Soothing Test
[0100] Method 1. The soothing effect of the test samples (oily ointment compositions of Examples 1-5) was evaluated by applying the test samples (oily ointment compositions of Examples 1-5) on the 3D epidermal skin membrane type to inhibit inflammatory factors (IL-1α, IL-8 and TSLP).
[0101] The specific method is as follows:
[0102] 1) Resuscitation cells: P1 generation keratinocytes (KC) were used to construct a 3D epidermal model;
[0103] 2) After 1 hour of collagen type I substrate, inoculate at 0.5M / transwell, add 500μL culture medium to each of the top and bottom, and culture at 37℃. Change the medium every other day;
[0104] 3) On the third day, the upper and lower culture media were replaced with CnT-PR-3D medium and cultured at 37°C overnight;
[0105] 4) On the fourth day, liquid phase culture was carried out, and the lower medium was replaced every other day until the culture was completed. The surface was treated with samples for 24 hours;
[0106] 5) Collect the lower culture medium and test the sample according to the ELISA operating instructions;
[0107] 6) Measure the OD value at 450 nm and calculate the IL-1α, IL-8 and TSLP content of the sample according to the standard curve.
[0108] The results are shown in Table 7 below.
[0109] Table 7: 3D skin model results of soothing test of the oily cream composition of Examples 1-5
[0110]
[0111] Method 2. The toxin level produced by the sample on skin cells was determined by a 2D cytotoxicity test, and the short-term (15 minutes) and long-term (24 hours) soothing effects of the sample on the skin were evaluated by testing the effects of the oily ointment compositions of sample Examples 1-5 on inflammatory factors (IL-8 and TSLP).
[0112] The specific method is as follows:
[0113] 1) Cultivating keratinocytes (KC),
[0114] 2) Collecting cell supernatant;
[0115] 3) Take out the required strips that have been restored to room temperature, set up standard wells, blank wells and sample wells (the oily paste composition of Examples 1-5), each with 50 μL;
[0116] 4) Add 100 μmL of horseradish peroxidase (HRP)-labeled antibody. Seal the reaction wells with a sealing film and incubate at 37°C for 60 min.
[0117] 5) Wash the plate three times, add 50 μL of substrate A and B to each well, and shake at room temperature in the dark for 15 min;
[0118] 6. Add 50 μL of stop solution and measure the OD value of each well at a wavelength of 450 nm within 15 minutes.
[0119] The results are shown in Tables 8-9 below.
[0120] Table 8: Experimental results of the oily ointment compositions of Examples 1-5 inhibiting IL-8 2D cells
[0121]
[0122] Table 9: Experimental results of the oily ointment compositions of Examples 1-5 inhibiting TSLP 2D cells
[0123]
[0124] As shown in Table 7, based on the 3D epidermal skin model, applying the oily ointment composition of Examples 1-5 can effectively inhibit the secretion of inflammatory factors IL-8, IL-1α and TSLP, indicating that the oily ointment composition of Examples 1-5 has a soothing effect; as shown in Tables 8 and 9, after 2D cell experiments, the oily ointment composition of Examples 1-5 significantly inhibited the secretion of inflammatory factors IL-8 and TSLP after 15 minutes and 24 hours, respectively, indicating that the oily ointment composition of Examples 1-5 has short-term and long-term soothing effects. The results of Tables 7-9 show that the oily ointment composition of Examples 1-5 has a soothing effect.
[0125] Experimental Example 4: Moisturizing Test
[0126] The moisturizing test in this experimental example is based on a 3D epidermal skin model Via Corneometer The skin moisture content tester (Courage+Khazaka electronic) was used to detect the change of skin moisture content to evaluate the moisturizing effect of the test sample (the oily ointment composition of Examples 1-5).
[0127] The specific method of moisturizing test is as follows:
[0128] 1) Group test:
[0129] Blank control group (BC), positive control group (PC) and sample group (the oily ointment composition of Examples 1-5);
[0130] 2) Drug administration test:
[0131] (1) According to the test group, transfer the model to a 6-well plate (add 0.9 mL EpiGrowth culture medium in advance) and mark the test group number on the 6-well plate;
[0132] (2) The BC group received no treatment, the PC group added the corresponding concentration of working solution, and the sample group evenly distributed the samples on the model surface and incubated them in CO2 culture (37°C, 5% CO2) for 24 h;
[0133] (3) After the incubation, the test substance remaining on the surface of the model was cleaned with sterile PBS solution, and the residual liquid inside and outside the model was wiped off with a sterile cotton swab.
[0134] 3) Skin moisture content test:
[0135] (1) Cleaning: Clean the oily paste composition on the surface of the model and gently wipe off the residual water on the surface with a cotton swab. After completion, prepare a 24-well plate according to the number of models and mark them accordingly. Add 0.3 mL of EpiGrowth culture medium to each well. Place the 24-well plate containing the model in the clean bench, open the lid of the 24-well plate, and let it stand for 30 minutes before measuring;
[0136] (2) Measurement: Wipe the moisture off the bottom of the model, remove the model ring, place it on the probe position of the tester, press the probe to measure, measure each model three times and take the average value.
[0137] 4) Calculation of improvement rate
[0138] Improvement rate (%) = (sample group - blank control group) / blank control group × 100%.
[0139] The results are shown in Table 10 below.
[0140] Table 10: Skin moisture content test results of the oily ointment composition of Examples 1-5
[0141]
[0142] From the results in Table 10, it can be seen that based on the 3D epidermal skin model, the skin moisture content of the samples of the oily ointment compositions of Examples 1-5 was significantly increased after application, indicating that the oily ointment compositions of Examples 1-5 have a moisturizing effect.
[0143] Experimental Example 5: Barrier Repair Test
[0144] This experimental barrier repair test uses sodium dodecyl sulfate (SDS) to stimulate the 3D epidermal skin model The barrier-enhancing function of the test samples (the oily cream compositions of Examples 1-5) was evaluated by detecting the changes in the content of filaggrin (FLG).
[0145] The specific method of barrier repair test is as follows:
[0146] 1) Sample grouping: divided into a blank control group, a negative control group, a positive control 1, a positive control 2 and a sample group (the oily ointment composition of Examples 1-5);
[0147] 2) Drug administration test:
[0148] (1) According to the test group, transfer the model to a 6-well plate (add 0.9 mL EpiGrowth culture medium in advance) and mark the test group number on the 6-well plate.
[0149] (2) 25 μL of 0.1% SLS solution was added to the surface of the NC group, PC group, and sample group and incubated for 30 min.
[0150] (3) After the incubation, the working solution of corresponding concentration was added to the PC group liquid, and the sample group evenly smeared the sample on the model surface and placed it in a CO2 incubator (37°C, 5% CO2) for 24 h.
[0151] (4) After the incubation, the test substance remaining on the surface of the model was cleaned with sterile PBS solution, and the residual liquid inside and outside the model was wiped off with a sterile cotton swab.
[0152] 3) ELISA test
[0153] After 24 hours of incubation, the culture medium of the 3D epidermal skin model was collected in a centrifuge tube. After collection, the samples for ELISA detection were placed in a -80°C refrigerator for freezing and stored, and the detection and analysis were performed according to the operating instructions of the ELISA kit.
[0154] 4) Immunofluorescence test
[0155] Take the model for testing, cut off the model, fix it with 4% paraformaldehyde, fix it for 24 hours, perform immunofluorescence detection, observe it under a microscope, and collect pictures (see Figure 1 ) and analyze.
[0156] 5) Calculation of FLG improvement rate
[0157] Improvement rate (%) = (sample group - negative control group) / negative control group × 100%;
[0158] The results are shown in Table 11 below.
[0159] Table 11: Experimental results of the oily ointment compositions of Examples 1-5 inhibiting TSLP 2D cells
[0160]
[0161] From Table 11 and Figure 1 The results show that based on the 3D epidermal skin model, the content of filaggrin (FLG) in the skin samples coated with the oily cream composition of Examples 1-5 increased significantly, indicating that the oily cream composition of Examples 1-5 has a barrier enhancement function.
[0162] Experimental Example 6: Consumer Testing
[0163] This test is a single-center, self-controlled, buttocks trial and a 2-week consumer use test. 35 healthy infants aged 0-1 years who were self-reported by their parents to have buttocks skin discomfort were selected as subjects. Each subject used the test product (the oily paste composition of Examples 1, 3 and 5) for 14 consecutive days, and product efficacy feedback was conducted in the form of a quantitative questionnaire. The content of the questionnaire includes the subject's buttocks skin condition before using the test product and the buttocks skin condition after 7 and 14 days of continuous use, as evaluated by the parents. The skin condition involves the improvement of skin dryness, improvement of skin roughness, improvement of skin redness, time to form a breathable film, effective isolation of defecation and urine duration, and effective average duration of redness relief.
[0164] The results are shown in Table 12 below.
[0165] Table 12: Consumer test results of the oily cream compositions of Examples 1, 3 and 5
[0166]
[0167] It can be seen from the results in Table 12 that according to the evaluation results of 35 healthy infant test subjects who reported that their parents had skin discomfort on their buttocks after 14 days of trial use, the oily paste compositions of Examples 1, 3 and 5 have moisturizing and soothing effects, are mild (non-irritating), can quickly form a protective film to effectively isolate feces and urine, soothe the skin, and provide a comfortable environment for the baby's buttocks.
Claims
1. An oily ointment composition, characterized in that: According to weight percentage, the composition comprises: 20-59% semi-solid oil, 0.5-85% vegetable oil, 5-15% vegetable wax, 0.5-5% antioxidant, 1-53% emulsifier, 0.05-16% thickener and 0.01-5% soothing agent.
2. The oily paste composition according to claim 1, characterized in that According to weight percentage, the composition comprises: 30-50% semi-solid oil, 10-65% vegetable oil, 5-10% vegetable wax, 0.5-3% antioxidant, 1-20% emulsifier, 0.05-10% thickener and 0.01-3% soothing agent.
3. The oily paste composition according to claim 1-2, characterized in that: The semi-solid oil is lanolin.
4. The oily paste composition according to claim 1-2, characterized in that: The vegetable oil is selected from at least one of solid vegetable oil and liquid vegetable oil.
5. The oily paste composition according to claim 1-2, characterized in that: The plant wax is selected from at least one of carnauba wax, candelilla wax, sumac wax, sunflower seed wax, narcissus poetICUS flower wax, lime flower wax, rice bran wax, wattle flower wax and olive oil unsaponifiable matter.
6. The oily paste composition according to claim 1-2, characterized in that: The antioxidant is selected from at least one of tocopherol and ascorbic acid ester.
7. The oily paste composition according to claim 1-2, characterized in that: The emulsifier is selected from at least one of polyglyceryl-2 triisostearate, polyglyceryl-2 diisostearate, polyglyceryl-2 oleate, polyglyceryl-10 decastearate, polyglyceryl-6 pentaoleate, polyglyceryl-10 decooleate and polyglyceryl-6 polyricinoleate.
8. The oily paste composition according to claim 1-2, characterized in that: The thickener is selected from at least one of dextrin palmitate, dextrin palmitate / ethylhexanoate and glyceryl behenate.
9. The oily paste composition according to claim 1-2, characterized in that: The soothing agent is selected from at least one of bisabolol, Centella asiatica extract, glycyrrhizin stearate, Lithospermum officinale extract, Perilla frutescens seed extract, Calendula officinalis extract and Olive extract.
10. The oily paste composition according to claim 4, characterized in that: The solid vegetable oil is selected from at least one of cocoa seed butter, avocado tree butter, Indian garcinia seed butter, mango seed butter and coconut oil.
11. The oily paste composition according to claim 4, characterized in that: The liquid vegetable oil is selected from at least one of jojoba seed oil, sunflower seed oil, meadowfoam seed oil, sea buckthorn seed oil, avocado tree oil, olive oil, camellia oil, almond oil, sweet almond oil, wheat germ oil, oat kernel oil, avocado oil, macadamia seed oil, evening primrose oil, rice bran oil, camellia seed oil and moringa seed oil.
12. A method for preparing the oily paste composition according to claims 1-11, characterized in that: The method comprises the following steps: S1: mixing the vegetable wax, vegetable oil and emulsifier under stirring conditions, and heating and keeping warm to obtain a phase A solution; S2: adding the semi-solid oil, antioxidant, soothing agent and thickener to the phase A solution obtained in the above step S1 in sequence, mixing under stirring conditions, and heating and keeping warm to obtain a phase B solution; S3: Cooling the phase B solution obtained in the above step S2 to a certain temperature and filtering it to obtain a phase C solution; S4: placing the phase C solution obtained in the above step S3 at a certain cold air channel temperature, without refrigeration, and filling under low wind until the paste solidifies to obtain the oily paste composition; or The phase C solution obtained in the above step S3 is placed in a naturally cooled state without refrigeration or blowing and filled until the paste solidifies to obtain the oily paste composition.
13. The method according to claim 12, characterized in that The method satisfies at least one of the following conditions: In step S1, the heating and heat preservation refers to heating to 85-90°C and keeping warm for 10-15 minutes; In step S2, the heating and heat preservation refers to heating to 85-90° C. and keeping warm for 10-15 minutes; In step S3, the certain temperature is 80-85°C; and In step S4, the certain cold air temperature is 15-20°C.
14. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product for improving diaper rash in infants and young children.
15. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product with a water-isolating effect.
16. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product with a moisturizing effect.
17. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product with a short-term soothing effect.
18. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product with a long-lasting soothing effect.
19. Use of the oily ointment composition according to any one of claims 1 to 11 or the oily ointment composition prepared by the method according to any one of claims 12 to 13 in preparing a skin care product having an effect of improving barrier function.
Citation Information
Patent Citations
Infant diaper rash cream and preparation process thereof
CN109044915A
Baby diaper rash cream and preparation method thereof
CN112263527A
